Compile Data Set for Download or QSAR
Found 80 with Last Name = 'karche' and Initial = 'v'
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM50575333(CHEMBL4857063)copy SMILES
Affinity DataIC50: 8nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM50575331(CHEMBL4868242)copy SMILES
Affinity DataIC50: 11nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM50575332(CHEMBL4869725)copy SMILES
Affinity DataIC50: 14nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM50575328(CHEMBL4868367)copy SMILES
Affinity DataIC50: 32nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM50575327(CHEMBL4848840)copy SMILES
Affinity DataIC50: 34nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387265(2,6- Difluoro-N-(2′- methyl-5′-(4-meth...)copy SMILEScopy InChI
Affinity DataIC50: 34nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM50575326(CHEMBL4868517)copy SMILES
Affinity DataIC50: 50nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM50575329(CHEMBL4859192)copy SMILES
Affinity DataIC50: 55nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387270(2,6- Difluoro-N-(5-(2- methyl-5-(4- methyl-5-oxo-4...)copy SMILEScopy InChI
Affinity DataIC50: 64nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387269(2- Chloro-N-(5-(5-(5,5- dimethyl-4-oxo-4,5- dihydr...)copy SMILEScopy InChI
Affinity DataIC50: 65nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387261(N-(5′- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxa...)copy SMILEScopy InChI
Affinity DataIC50: 69nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
LigandPNGBDBM50575331(CHEMBL4868242)copy SMILES
Affinity DataIC50: 76nMAssay Description:Inhibition of Orai1/STIM1 (unknown origin) expressed in HEK293 cells assessed as reduction in Ca2+-release activated Ca2+ entry current by manual pat...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387266(N-(5′- (4-Ethyl-5-oxo-4,5- dihydro-1,3,4- ...)copy SMILEScopy InChI
Affinity DataIC50: 78nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387272(N-(5-(5- (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol-...)copy SMILEScopy InChI
Affinity DataIC50: 94nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387277(N-(2,6- Difluorophenyl)-5-(5- (5,5-dimethyl-4-oxo-...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387269(2- Chloro-N-(5-(5-(5,5- dimethyl-4-oxo-4,5- dihydr...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387268(N-(2′- Chloro-5′-(4-methyl- 5-oxo-4,5-...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387267(2,6- Difluoro-N-(2′- methoxy-5′-(4- me...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387266(N-(5′- (4-Ethyl-5-oxo-4,5- dihydro-1,3,4- ...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387265(2,6- Difluoro-N-(2′- methyl-5′-(4-meth...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387264(N-(3′- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxa...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387261(N-(5′- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxa...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387263(N-(2′- acetamido-5′-(5,5- dimethyl-4-o...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387271(2,6- Difluoro-N-(5-(2- methoxy-5-(4- methyl-5-oxo-...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387272(N-(5-(5- (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol-...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387262(N-(5′- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxa...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387280(N-(2,6- Difluorophenyl)-5-(2- methyl-3-(4-methyl- ...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387279(5-(2- (Difluoromethoxy)-5- (4-methyl-5-oxo-4,5- di...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387278(N-(2,6- Difluorophenyl)-5-(2- ethyl-5-(4-methyl-5-...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387270(2,6- Difluoro-N-(5-(2- methyl-5-(4- methyl-5-oxo-4...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387276(5-(5- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxazol- 3-...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387274(N-(2,6- Difluorophenyl)-5-(5- (5,5-dimethyl-4-oxo-...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387273(US10292981, Example 135)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
LigandPNGBDBM50575336(CHEMBL4753998)copy SMILES
Affinity DataIC50: 119nMAssay Description:Inhibition of Orai1/STIM1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387297(US10292981, Example 121)copy SMILEScopy InChI
Affinity DataIC50: 150nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387294(US10292981, Example 78)copy SMILEScopy InChI
Affinity DataIC50: 171nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387281(N-(5-(5- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxazol-...)copy SMILEScopy InChI
Affinity DataIC50: 178nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM50575331(CHEMBL4868242)copy SMILES
Affinity DataIC50: 183nMAssay Description:Inhibition of IL2 in thapsigargin stimulated human whole bloodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM50575330(CHEMBL4872805)copy SMILES
Affinity DataIC50: 227nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387290(N-(5- (5,5-Dimethyl-4,5- dihydroisoxazol-3- yl)-2-...)copy SMILEScopy InChI
Affinity DataIC50: 328nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82F4QPubMed
TargetNuclear factor of activated T-cells, cytoplasmic 2(Homo sapiens (Human))
Bristol-Myers Squibb Company

LigandPNGBDBM387273(US10292981, Example 135)copy SMILEScopy InChI
Affinity DataIC50: 500nMAssay Description:HEK 293 cells were stably transfected with a NFAT-Luc reporter gene. 30,000-80,000 cells were seeded per well. Test compounds from this invention wer...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetNuclear factor of activated T-cells, cytoplasmic 2(Homo sapiens (Human))
Bristol-Myers Squibb Company

LigandPNGBDBM387315(4- Methyl-N-(2′-methyl- 3′-(4-methyl-5...)copy SMILEScopy InChI
Affinity DataIC50: 500nMAssay Description:HEK 293 cells were stably transfected with a NFAT-Luc reporter gene. 30,000-80,000 cells were seeded per well. Test compounds from this invention wer...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetNuclear factor of activated T-cells, cytoplasmic 2(Homo sapiens (Human))
Bristol-Myers Squibb Company

LigandPNGBDBM387264(N-(3′- (5,5-Dimethyl-4-oxo- 4,5-dihydroisoxa...)copy SMILEScopy InChI
Affinity DataIC50: 500nMAssay Description:HEK 293 cells were stably transfected with a NFAT-Luc reporter gene. 30,000-80,000 cells were seeded per well. Test compounds from this invention wer...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetNuclear factor of activated T-cells, cytoplasmic 2(Homo sapiens (Human))
Bristol-Myers Squibb Company

LigandPNGBDBM387280(N-(2,6- Difluorophenyl)-5-(2- methyl-3-(4-methyl- ...)copy SMILEScopy InChI
Affinity DataIC50: 500nMAssay Description:HEK 293 cells were stably transfected with a NFAT-Luc reporter gene. 30,000-80,000 cells were seeded per well. Test compounds from this invention wer...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387307(US10292981, Example 138)copy SMILEScopy InChI
Affinity DataIC50: 550nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387306(US10292981, Example 136)copy SMILEScopy InChI
Affinity DataIC50: 550nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387301(N-(2′- (allyloxy)-5′-(5,5- dimethyl-4-...)copy SMILEScopy InChI
Affinity DataIC50: 550nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387299(N-(5-(5- (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol-...)copy SMILEScopy InChI
Affinity DataIC50: 550nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387297(US10292981, Example 121)copy SMILEScopy InChI
Affinity DataIC50: 550nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
TargetInterleukin-2(Homo sapiens (Human))TBA
LigandPNGBDBM387296(N-(5-(5- (5,5-dimethyl-4-oxo- 4,5-dihydroisoxazol-...)copy SMILEScopy InChI
Affinity DataIC50: 550nMAssay Description:Jurkat T cells were seeded at a density of 0.5 to 1 million cells per well in RPMI medium. Test compounds from this invention were added to the cells...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D50Q8BUS Patent
Displayed 1 to 50 (of 80 total ) | Next | Last >>
Jump to: